WS #11590
Crinetics Pharmaceuticals surges 99% premarket on $10B buyout from Vertex at $85/share, a major M&A signal in biotech.
Crinetics buyout by Vertex at $85/share
Crinetics Pharmaceuticals surges 99% premarket on $10B buyout from Vertex at $85/share, a major M&A signal in biotech.